Stock Track | Anteris Technologies Global Soars 5% After-hours Following Successful US IPO Pricing at $6 Per Share

Stock Track

Dec 14, 2024

Anteris Technologies Global (AVR), an Australian medical device company, saw its stock soar by 5% in after-hours trading on Friday, following the successful pricing of its US initial public offering (IPO).

The company announced late Thursday that it had priced its US IPO at $6.00 per share for 14.8 million shares, raising approximately $88.8 million in gross proceeds. Anteris also granted underwriters a 30-day option to purchase up to an additional 2.2 million shares.

The strong demand for Anteris' IPO shares, which are set to begin trading on the Nasdaq under the ticker "AVR" on Friday, reflects investor confidence in the company's innovative DurAVR transcatheter heart valve technology and its growth prospects in the expanding medical device market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1183723274"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1183723274\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1183723274?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-14 06:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1183723274","market":"hk","top_or_hot":-1,"title":"Stock Track | Anteris Technologies Global Soars 5% After-hours Following Successful US IPO Pricing at $6 Per Share","media":"Stock Track","content":"<p>Anteris Technologies Global (AVR), an Australian medical device company, saw its stock soar by 5% in after-hours trading on Friday, following the successful pricing of its US initial public offering (IPO).</p>\n\n<p>The company announced late Thursday that it had priced its US IPO at $6.00 per share for 14.8 million shares, raising approximately $88.8 million in gross proceeds. Anteris also granted underwriters a 30-day option to purchase up to an additional 2.2 million shares.</p>\n\n<p>The strong demand for Anteris' IPO shares, which are set to begin trading on the Nasdaq under the ticker \"AVR\" on Friday, reflects investor confidence in the company's innovative DurAVR transcatheter heart valve technology and its growth prospects in the expanding medical device market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Anteris Technologies Global Soars 5% After-hours Following Successful US IPO Pricing at $6 Per Share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Anteris Technologies Global Soars 5% After-hours Following Successful US IPO Pricing at $6 Per Share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2024-12-14 06:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Anteris Technologies Global (AVR), an Australian medical device company, saw its stock soar by 5% in after-hours trading on Friday, following the successful pricing of its US initial public offering (IPO).</p>\n\n<p>The company announced late Thursday that it had priced its US IPO at $6.00 per share for 14.8 million shares, raising approximately $88.8 million in gross proceeds. Anteris also granted underwriters a 30-day option to purchase up to an additional 2.2 million shares.</p>\n\n<p>The strong demand for Anteris' IPO shares, which are set to begin trading on the Nasdaq under the ticker \"AVR\" on Friday, reflects investor confidence in the company's innovative DurAVR transcatheter heart valve technology and its growth prospects in the expanding medical device market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AVR","symbol_name":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)","start_time":0,"source_url":"","article_id":"1183723274","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1183723274","pubTimestamp":1734127334,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Anteris Technologies Global , an Australian medical device company, saw its stock soar by 5% in after-hours trading on Friday, following the successful pricing of its US initial public offering .The company announced late Thursday that it had priced its US IPO at $6.00 per share for 14.8 million shares, raising approximately $88.8 million in gross proceeds. Anteris also granted underwriters a 30-day option to purchase up to an additional 2.2 million shares.The strong demand for Anteris' IPO shar","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AVR":"Anteris Technologies Global (NASDAQ Uplisting/Dual Listing)"},"translate_title":"股票追踪Anteris Technologies Global在美国IPO成功定价为每股6美元后盘后飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVR":1},"content_text":"Anteris Technologies Global (AVR), an Australian medical device company, saw its stock soar by 5% in after-hours trading on Friday, following the successful pricing of its US initial public offering (IPO).\nThe company announced late Thursday that it had priced its US IPO at $6.00 per share for 14.8 million shares, raising approximately $88.8 million in gross proceeds. Anteris also granted underwriters a 30-day option to purchase up to an additional 2.2 million shares.\nThe strong demand for Anteris' IPO shares, which are set to begin trading on the Nasdaq under the ticker \"AVR\" on Friday, reflects investor confidence in the company's innovative DurAVR transcatheter heart valve technology and its growth prospects in the expanding medical device market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}